Skip to content

Clinical trials

Phase 3 Triple Negative Breast Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Phase: Phase 3 Country / region: United Kingdom Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20161
20173
20182
20192
20201
20211
20224
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting4
Recruiting4
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche6
Merck Sharp & Dohme LLC4
Gilead Sciences3
AbbVie1
AstraZeneca1
GlaxoSmithKline1
Health Clinics Limited1
Istituto Oncologico Veneto IRCCS1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms19
Breast Neoplasms5
Neoplasms3
Brain Neoplasms1
Breast Diseases1
Colonic Neoplasms1
Neoplasm Metastasis1
Neoplasms by Site1
Ovarian Neoplasms1
Pancreatic Neoplasms1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.